Integrated vascular delivery system

Information

  • Patent Grant
  • 11577052
  • Patent Number
    11,577,052
  • Date Filed
    Wednesday, February 19, 2020
    4 years ago
  • Date Issued
    Tuesday, February 14, 2023
    a year ago
Abstract
An integrated vascular delivery system and method of use, the system including: a frame having a catheter hub that provides a first anchoring point on the patient and receives a catheter insertable in the patient to transfer fluid at an insertion site, a stabilization hub that provides a second anchoring point on the patient, at least one lateral member extending between the catheter and stabilization hubs, and a fluidic channel. The frame operates in a folded configuration in which the hubs are coupleable and an unfolded configuration in which the anchoring points are distributed around the insertion site to anchor the frame to the patient, thereby stabilizing the catheter. In some embodiments, the system further includes a septum that helps prevent fluid leakage from the catheter hub, or a needle shield that covers the distal end of a needle used during catheter insertion.
Description
BACKGROUND OF THE INVENTION
Field of the Invention

This invention relates generally to the medical care field, and more specifically to an improved vascular delivery system in the intravenous therapy field.


Description of the Related Art

Patients undergoing medical treatment often require a form of intravenous (IV) therapy, in which a fluid is administered to the patient through a vein of the patient. IV therapy is among the fastest ways to deliver fluids and medications into the body of the patient. Intravenously infused fluids, which typically include saline, drugs, blood, and/or antibiotics, are conventionally introduced to the patient through a flexible catheter positioned at any of several venous routes, such as peripheral veins and central veins.


SUMMARY OF THE INVENTION

To set up IV therapy with conventional devices and methods, the caregiver positions the catheter over the selected vein and uses a needle within the catheter to pierce the skin and allow insertion of the distal end of the catheter into the vein. The proximal end of the catheter, relative to the midline of the catheter, is fixed to the end of a catheter hub that is proximal relative to the midline of the patient. The caregiver connects the catheter to a fluid supply through external tubing, including extension tubing that is typically attached to the catheter hub and that the caregiver typically bends into a U-shape to accommodate the typical opposite positions of the catheter and IV fluid source. To avoid unscheduled IV line restarts, the catheter and tubing are typically secured against the skin of the patient with tape or similar catheter stabilization devices (CSDs) such as adhesive stabilizing pads that restrain the catheter hub.


However, these conventional devices and methods for IV therapy have drawbacks. The extension tubing may catch on nearby obstacles during patient movement or caregiver manipulation, which may cause painful vein irritation and comprise the IV. Tape and other existing CSDs are not optimal for stabilization because securing the round, rigid, and bulky components such as the catheter and tubing against relative flat skin can be difficult and ineffective. Tape and other existing CSDs do not fully prevent the catheter from moving within the vein, which leads to patient-endangering complications including catheter dislodgement, infiltration (fluid entering surrounding tissue instead of the vein) and phlebitis (inflammation of the vein). Adhesive stabilizing pads tend to result in other undesired effects, such as skin irritation and/or breakdown due to prolonged concentrated adhesion to the skin. Furthermore, tape and current CSDs do not prevent the catheter from painfully and dangerously pivoting around the insertion site and moving within the vein.


Thus, there is a need in the medical care field to create an improved vascular delivery system. This invention provides such an improved vascular delivery system.





BRIEF DESCRIPTION OF THE DRAWINGS


FIGS. 1A, 1B, 2, and 3 are schematics of the integrated vascular delivery system of a preferred embodiment;



FIGS. 4, 5A-5D, and 6A-6C are schematics of variations of the integrated vascular delivery system;



FIGS. 7A-7D, 8A, 8B, 9 and 10 are schematics of variations of mechanisms for coupling the catheter hub and stabilization hub in the folded configuration of the integrated vascular delivery system of a preferred embodiment;



FIGS. 11A-11E, 12A-12C, 13A, 13B, 14A, 14B, 15A-15E, 16A, 16B, 17A, and 17B are schematics of variations of the septum in the integrated vascular delivery system of a preferred embodiment;



FIGS. 18A, 18B, 19A, 19B, 20, 21A, 21B, 22A, 22B, and 23 are schematics of variations of the needle shield in the integrated vascular delivery system of a preferred embodiment; and



FIGS. 24-27 are schematics of the method of using an integrated vascular delivery system of a preferred embodiment.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

The following description of preferred embodiments of the invention is not intended to limit the invention to these preferred embodiments, but rather to enable any person skilled in the art to make and use this invention.


As shown in FIGS. 1-3, the integrated vascular delivery system 100 of a preferred embodiment includes: a frame 110 having a catheter hub 120 configured to receive a catheter 122, a stabilization hub 130, and at least one lateral member 140 extending between the catheter hub and stabilization hub; and a fluidic channel 150 that fluidically communicates with the catheter. The catheter hub 120 preferably provides a first anchoring point 112 on the patient and is configured to receive a catheter 122 insertable in a patient to transfer fluid at an insertion site 102, and the stabilization hub 130 preferably provides a second anchoring point 112′ on the patient. The frame 110 preferably operates in a folded configuration 114 in which the catheter and stabilization hubs may be coupled, and in an unfolded configuration 116 in which the first and second anchoring points are distributed around the insertion site 102 to anchor the frame 110 to the patient, thereby stabilizing the catheter. For instance, in a preferred embodiment the first and second anchoring points are on opposite sides of the insertion site, such as proximal and distal to the side, or on opposite lateral sides of the insertion site. The system 100 preferably includes a catheter 122, such as a catheter embedded in the catheter hub 120, but may the system may alternatively be configured to receive and/or couple to a separate catheter before or after insertion into the patient. In some embodiments, the system may further include a septum 170 that helps prevent escape or leakage of fluids from the fluidic channel 150. In some embodiments, the system may further include a needle shield 190, coupled to the catheter hub and/or stabilization hub, that engages a distal portion of a needle 104 used for inserting the catheter 122 into the patient. The system may be used to obtain access to a blood vessel of a patient, such as one undergoing intravenous (IV) therapy. The system may be used to administer drugs, antibiotics, saline, blood, or any suitable fluid to a patient, and/or to remove fluid from the patient. The system may be used to create, stabilize, and maintain an IV line at an insertion site on a peripheral vein or artery such as on the arm, hand, or leg, or for central venous access on the neck, chest, abdomen, or any suitable IV location. However, the system may be used to create, stabilize, and maintain any suitable catheter-based access to a patient, such as catheters for transfer of cerebrospinal fluid.


Integrated Vascular Delivery System-Frame and Fluidic Channel


The frame 110 of the integrated vascular delivery system functions to stabilize the system and the catheter on the patient. As shown in FIGS. 1-3, the frame 110 preferably includes a catheter hub 120 that provides a first anchoring point 112 on the patient, a stabilization hub 130 that provides a second anchoring point 112′ on the patient, and at least one lateral member 140 that extends between the catheter and the stabilization hubs. In alternative embodiments of the frame 110, the frame may include any suitable number of hubs and any suitable number of lateral members, such that the frame forms an enclosed or partial, non-enclosed perimeter of any suitable shape and size around the insertion site 102. The frame preferably allows visualization of the insertion site of the catheter, such as by leaving an open uncovered area around the catheter, although alternatively the system may include a cover that is transparent, translucent, opaque, or any suitable kind of materials, that extends over the frame to cover the insertion site and/or catheter.


The catheter hub 120 is configured to receive a catheter 122, which may be embedded in the catheter hub and integrally part of the system, or may be a separate catheter that is coupled to the catheter hub 120 before or after insertion into the patient, such as with a snap fit into the catheter hub 120. Alternatively, any suitable portion of the frame may be configured to receive the catheter. The catheter hub 120 preferably includes a channel 124, concentrically aligned with the catheter, that may receive a needle 104 used during insertion of the catheter into the patient. As shown in FIG. 3, the catheter hub and/or stabilization hub may include a sensor 126 that measures a biometric parameter such as temperature, blood pressure, or pulse rate of the patient. The sensor 126 may additionally and/or alternatively sense any suitable parameter such as one pertaining to the fluid passing through the catheter, such as pH or flow rate.


The catheter hub and/or stabilization hub may have a relatively wide and thin profile, which may help distribute forces over a greater area on the skin and decreases the chances of the patient developing skin irritations, sores, and other degradations. The thin profile may help decrease the risk of the risk of the hub catching or snagging on bed equipment or other nearby obstacles that could cause the catheter to move within the vein and cause complications such as catheter dislodgement, infiltration, and phlebitis. However, the catheter and stabilization hubs may have any suitable shape. The catheter and stabilization hubs may include a rigid or semi-rigid plastic or other suitable material, and/or softer material. For example, one or both hubs may include a rigid core overmolded with a softer material such as silicone.


The system may further include at least one extension tube 160 and/or a fluid supply adapter 162, coupled to the catheter hub 120 and/or stabilization hub 130, that delivers fluid from a fluid supply to the fluidic channel 150. The extension tube 160, which provides stress relief if the system is jostled (such as from patient movement or caregiver manipulations), is preferably made of flexible tubing such as polymer tubing, but may alternatively be a passageway made of any other suitable material. The extension tube 160 is preferably long enough to provide stress relief if needed, but short enough to reduce the chances of the extension tube catching or snagging on nearby obstacles. In another variation, the fluidic channel 150 and/or extension tube 160 may be coiled like a spring to provide stress relief. The length of the extension tube may alternatively be any suitable length, and may depend on the specific application of the system. Other dimensions of the extension tube, such as outer diameter and inner diameter, may also depend on the specific application of the system. The fluid supply adapter 162 preferably includes a connector that attaches the extension tube to a fluid supply (e.g. pole-mounted IV bag, syringe, or pump that supplies fluid through tubing). The connector may be a standard female luer lock connector (FIGS. 5A and 5B) or Y-connector (FIGS. 5C and 5D) that commonly interfaces with conventional IV bags. Alternatively, the connector may be any suitable male or female connector that is adapted to interface with a fluid supply. Furthermore, the luer lock connector or other fluid supply adapter may be coupled directly to the catheter hub and/or stabilization hub, rather than to an extension tube.


In alternative versions of the system, the system may include more than one extension tube 160 and/or fluid supply adapter 162, to facilitate delivering fluid from multiple fluid supplies simultaneously to the system. For example, in an embodiment of the system that includes two fluidic channels, the system may include a first extension tube that delivers a first fluid to a first fluidic channel, and a second extension tube that delivers a second fluid to the second fluidic channel. However, two extension tubes may useful in applications involving the administering of two separate fluids through the same fluidic channel 150 and catheter.


The lateral member 140 functions to provide structural stability to the frame 110 by stabilizing the catheter hub 120 relative to the stabilization hub 130. As shown in FIGS. 1-3, the frame preferably includes two lateral members 140 and 140′ that, with the catheter and stabilization hubs, form a perimeter around the catheter. The two lateral members may be approximately parallel, or may be in any crossed, non-parallel or other suitable orientation. However, as shown in FIG. 4, the frame 110 may include only a partial perimeter around the catheter, such as with one lateral member instead of two. Each lateral member 140 may be flexible, such as to allow the catheter and stabilization hubs to move relative to one another with a significant number of degrees of freedom, including displacement in the compression direction (and subsequent displacement in the tension direction) along the axis of the catheter, displacement in both directions along the other two axes, twisting in both directions along the axis of the catheter, and bending in both directions along the other two axes. In particular, the lateral member 140 may be reversibly bendable to allow the frame 110 to be in a folded configuration in which the catheter and stabilization hubs are coupleable. One or more lateral members may be tubular. For example, the lateral member may be a generally straight, soft, and flexible hollow channel like medical tubing, but may be any suitable structure with a lumen.


The fluidic channel 150 functions to deliver fluid from a fluid supply to the catheter, and in some embodiments, deliver fluid to and from the catheter, such as transferring fluid removed from the patient through the catheter to an external reservoir. As shown in FIG. 2, at least a portion of the fluidic channel 150 may be fixed within at least one of the hubs and/or within a tubular lateral member. As shown in FIGS. 6A-6C, at least a portion of the fluidic channel 150 may be additionally and/or alternatively be external to the hubs and lateral members. For instance, at least a portion of the fluidic channel 150 may be molded to an external surface of the catheter hub, the stabilization hub, and/or lateral member. The fluidic channel 150 preferably includes a turnabout portion 152 in which fluid flows in a direction different from that within the catheter 122. In particular, the turnabout portion 152 preferably directs the fluid flow to a direction opposite of that within the catheter, or in an approximately 180-degree turn. The turnabout portion 152 of the fluidic channel 150 may be fixed or embedded within the catheter hub and/or stabilization hub. In one exemplary application of the system, the catheter is inserted in the patient such that its penetrating end points proximally towards the heart of the patient, and the turnabout portion of the fluidic channel 150 allows a stand supporting the IV bag or other fluid supply to be kept near the head of a bed, or otherwise proximal to the insertion site as is typically practiced in patient treatment settings. The internalized fluid flow turn in the turnabout portion 152 of the fluidic channel 150 reduces the number of external structures that can get caught or snagged on nearby obstacles and consequently disturb the catheter and IV setup. Another effect of the turnabout portion is that if external tubing in the IV setup is pulled or caught, the turnabout portion may enable the frame 110 to stabilize the catheter more effectively by causing the catheter to be pulled further into the patient. For example, in a common catheter placement in which the catheter is placed on the forearm with its distal end pointing proximally toward the elbow of the patient, if the external tubing is accidentally pulled posteriorly towards the patient, the tubing will in turn pull the turnabout portion of the fluidic channel 150 and the catheter hub 120 toward the patient, thereby pulling the catheter further into the blood vessel of the patient rather than displacing the catheter from the insertion site.


In some variations, the system may include one, two, or any suitable number of fluidic channels. For instance, a second fluidic channel 150 may pass through a second lateral member 140. The second fluidic channel 150 preferably receives a second fluid, which may be the same or different from the first fluid supplied to the first fluidic channel 150. As shown in FIGS. 5A-5C, the system may further include a second extension tube 160 that supplies a second fluid to the frame and catheter. However, as shown in FIG. 5D, the system may include only one extension tube 160 that supplies fluid to one or multiple fluidic channels. The fluidic channels may have separate inlets on the stabilization hub 130 (FIGS. 5A and 5C), or may share the same inlet on the stabilization hub in which flow may be regulated with valves or other fluid control means (FIGS. 5B and 5D). In one variation, the first and second fluidic channels preferably fluidically communicate with the same catheter in the catheter hub 120, coupled to the catheter at the same point (FIGS. 5A and 5B) or different points (FIG. 5C) along the length of the catheter or channel. In this variation, the system preferably includes a flow control system 154 that selectively restricts flow of one or both of the fluids to the catheter and therefore to the patient. The flow control system 154 may include one or more valves 156, such as at the extension tubes (FIGS. 5A and 5B), at the junction between the fluidic channel 150 and the catheter (FIGS. 5C and 5D) or any suitable location. The flow control system may additionally and/or alternatively use pressure drops, vents, or any suitable technique for controlling fluid flow among the fluidic channels and catheter. The flow control system may also be present in an embodiment that includes only one fluidic channel 150. In another variation, the first and second fluidic channels preferably fluidically communicate with a catheter with dual lumens, such that one catheter lumen is coupled to the first fluidic channel and another catheter lumen is coupled to a second fluidic channel. In yet another variation, the first and second fluidic channels fluidically communicate with separate catheters. Additional variations expand on these variations with three or more fluidic channels.


As best shown in FIG. 3, the frame 110 preferably operates in a folded configuration 114 in which the catheter hub 120 and stabilization hub 130 may be coupled to one another and in an unfolded configuration 116 in which the first and second anchoring points are distributed around the insertion site. To facilitate a folded configuration, the frame 110 preferably allows the catheter hub 120 and stabilization hub 130 to move relative to one another with a significant number of degrees of freedom. In particular, the frame is preferably reversibly bendable or foldable to fold the catheter and stabilization hubs toward each other, or to pass one of the hubs over and/or under the other hub.


In the folded configuration 114, the catheter hub 120 and stabilization hub 130 may be coupled to one another. With the catheter and stabilization hubs coupled, the hubs experience the same movement relative to a needle 104 being passed into the catheter hub 120 and catheter, such as during insertion of the catheter in the patient. In a first variation, the catheter hub 120 and stabilization hub 130 may be coupled to one another by interaction of the needle 104 with the catheter hub 120 and/or stabilization hub 130. In one example of this variation, as shown in FIGS. 7A-7D, the stabilization hub 130 includes an extension 132, and the catheter hub 120 may include a slot 128 or other recess that receives the extension 132, although in another example the catheter hub 120 may include the extension 132 and the stabilization hub 130 may include the slot 120. The extension 132 defines a through hole 134, such that when the extension 132 is inserted into the slot 128, the through hole 134 is substantially aligned with a needle-receiving channel 124 of the catheter hub 120. In this variation, the frame 110 may be folded into the folded configuration during catheter insertion into the patient by a user (e.g. medical practitioner) who couples the catheter and stabilization hubs together by passing the needle 104 through the channel 124 of the catheter hub 120 and through the through hole 134 of the extension 132. Alternatively, the frame 110 may be folded and/or the needle 104 may be passed through the extension and slot of the hubs during manufacturing, such as during assembly and/or packaging. When the needle 104 is withdrawn from the hubs, the hubs may be decoupled and the frame 110 may be unfolded into the unfolded configuration. As shown in FIGS. 8A and 8B, the extension 132 may be retractable into the hub when the extension is no longer needed, such as when the frame 110 is in the unfolded configuration and ready for securement to the patient. The catheter hub and stabilization hub may include one, two, or any suitable number of extensions and/or slots. However, the catheter hub 120 and/or stabilization hub 130 may additionally and/or alternatively interact with the needle in any suitable manner (e.g., with a housing that surrounds the needle) to facilitate selective coupling of the catheter and stabilization hubs.


In a second variation, the catheter hub 120 and stabilization hub 130 may be coupled to one another by mutually interacting a third structural element. For example, as shown in FIG. 9, a block 136 may couple to both the catheter hub 120 and the stabilization hub 130 when the frame 110 is in the folded configuration. Although the block 136 is shown in FIG. 9 to have a particular geometry, the block may include a switch, latch, plug, and/or any suitable fastener or other mechanism. Removal of the block 136 may facilitate the decoupling of the catheter hub 120 and stabilization hub, such that frame may be in the unfolded configuration. As another example, as shown in FIG. 10, a needle or needle system 104′ may couple to both the catheter hub 120 and the stabilization hub 130 when the frame is in the folded configuration, such as during catheter insertion. Following catheter insertion, removal of the needle system 104′ may facilitate the decoupling of the catheter hub 120 and stabilization hub.


In a second variation, the catheter hub 120 and stabilization hub 130 may be coupled to one another in a slidable manner. For example, one of the hubs may have side grooves or channels, and the other hub may have side ridges that slidingly engage with the grooves of the other hub when the frame 110 is in the folded configuration. Other examples of this variation may include tabs inserted into slots, or any suitable mechanism.


In a third variation, the catheter hub 120 and stabilization hub 130 may be coupled to one another with snaps, latches, magnets, and/or any suitable fastener when the frame 110 is folded into the folded configuration. The fastener may be a separate piece that is mutually coupled to the catheter and stabilization hubs. Additional variations of the coupling of the catheter hub and stabilization hub include various combinations of the above variations. Furthermore, the catheter hub and stabilization hub may be coupled in any suitable manner, with or without the cooperation of the needle to help secure or lock the coupling of the catheter hub and stabilization hub.


In the unfolded configuration 116, as shown in FIGS. 1A and 1B, the catheter hub 120 and stabilization hub 130 are decoupled such that the frame 110 may be secured to the patient such that the first and second anchoring points 112 and 112′ are distributed around the insertion site 102 of the catheter, thereby stabilizing the catheter. The frame 110 is preferably secured to the patient by securing the catheter hub 120 and stabilization hub 130 to the patient at the first and second anchoring points, respectively. However, the frame 110 may additionally and/or alternatively be secured by securing only the catheter hub 120, only the stabilization hub 130, the lateral members 140 and/or any suitable portion of the frame 110. The frame may alternatively stabilize the catheter at anchoring points located at any suitable locations relative to the catheter insertion site. The frame 110, when secured to the patient, enables the integrated vascular delivery system to stabilize the catheter more effectively than conventional catheter securement devices that stabilize the catheter on only one side of the insertion site, because stabilizing the catheter on two different sides of the insertion site reduces pivoting motions of the catheter that may occur during normal patient movement and/or caregiver manipulates of the IV setup. The frame 110 is preferably secured to the patient with tape, but may additionally and/or alternatively be secured with an adhesive located on the underside of the catheter hub and/or stabilization hub; an elastic strap; a strap fastened with fasteners such as hooks, hook and loop, or magnets; or any suitable securement mechanism.


In one alternative embodiment, as shown in FIG. 6A-6C, the frame 110 includes one catheter hub, two stabilization hubs located on an opposite side of the frame as the catheter hub, two lateral members each connecting the catheter and a respective stabilization hub, and a fluidic channel. In this variation, each hub provides a respective anchoring point, such that the overall frame 110 includes three anchoring points 112, 112′ and 112″. In other examples, the frame may include any suitable number of anchoring points distributed equally or unequally around the insertion site 102. As shown in FIG. 6A, the catheter hub 120, stabilization hubs 130, and lateral members 140 may be integrated in a single piece. The single piece may include a single kind of material, or may include a rigid core of a first material (e.g. a rigid material such as plastic) and an outer layer of a second material (e.g. soft material such as silicone) covering the rigid core.


Other variations of catheter hub, stabilization hub, and lateral member configurations may be similar to that described in U.S. application Ser. No. 12/855,013 entitled “Integrated vascular delivery system”, which is incorporated in its entirety by this reference. Furthermore, the frame may include a catheter hub and a stabilization hub, but lack a lateral member; for example, the catheter hub and stabilization hub may be coupled together in a hinged manner such that the frame can operate in folded (“closed hinge”) and unfolded (“open hinge”) configurations.


Integrated Vascular Delivery System—Septum


The catheter hub 120 preferably further includes a septum 170 that functions to seal the internal channel 124 of the catheter hub 120 after withdrawal of the insertion needle 104 after catheter insertion, to prevent escape or leakage of blood and other potential biohazards or other fluids from the catheter hub 120. The septum 170 is preferably coupled to the catheter hub 120, preferably disposed within an internal channel 124 of the catheter hub, and may be concentrically aligned with the catheter. The septum 170 is preferably coupled to the catheter hub 120 and includes a primary seal 172 and a secondary seal 174. The primary seal 172 is an inner seal that functions as a first defense against fluid escaping, and the secondary seal 174 is an outer seal that functions as a second defense against fluid escaping. In some embodiments, the septum 170 may include fewer or more seals similar to the primary and secondary seals, which may be suitable for some applications to modify the amount of fluid leakage protection. The septum preferably defines a cavity 176 between the primary and secondary seals that may contain trapped fluid that passes through the primary seal. The cavity 176 may be larger than the diameter of the needle 104 to reduce frictional force on the needle during needle insertion through the septum, thereby increasing the ease of passing the needle through the septum. However, the cavity may alternatively be closely fit, and/or may include a material with a lower friction coefficient and/or fluid absorbent material.


The septum 170 may include an elastomeric material, and may have a diameter slightly larger than the channel 124 within the catheter hub 120, such that compression of the septum 170, when assembled in the channel, seals the annular gap between the outer circumferential edges of the septum and the walls of the channel within the catheter hub 120, thereby preventing fluid from escaping through the annular gap, and further maintaining the coupling between the septum 170 and the catheter hub 120, similar to a press fit. The septum 170 may additionally and/or alternatively include a sealant material applied to the outer edges of the septum to prevent passage of fluid between the septum and catheter hub walls, and/or be temporarily or permanently bonded to the catheter hub such as with sonic welding, chemical welding, or adhesive.


As shown in FIGS. 11A-11E, in a preferred embodiment, the septum 170 includes a rigid core 180 and a compressible plug 188 coupled to the rigid core. The rigid core is a framework that preferably includes a back wall 182 with aperture 186 and wall members 184 extending from the ball wall. The back wall 182 may provide a flange that helps seat the septum 170 within the catheter hub 120. The wall members 184 are preferably substantially parallel, but may be in any suitable relative orientation that defines a gap between the wall members. The compressible plug 188 is coupled partially or wholly around the rigid core, covering or filling the aperture 186 and surrounding the wall members 184 to define a cavity 176 in a central portion of the septum. One end of the compressible plug forms the primary seal 172, and the other end of the compressible plug covering the aperture of the back wall forms the secondary seal 174. The aperture 186 of the back wall allows needle puncture access in and out of the septum cavity (and the catheter). The rigid core 180 is preferably made of a rigid plastic such as polycarbonate, acrylonitrile butadiene styrene (ABS) or other styrene, and the compressible plug 188 preferably includes an elastomeric material such as isoprene or silicone. However, the rigid core and compressible plug may include any suitable materials. The compressible plug is preferably coupled to the rigid core in an overmolding manufacturing process, but may additionally and/or alternatively include other coupling mechanisms or processes such as adhesive.


In a first alternative variation, as shown in FIGS. 12A-12C, the septum is a split septum 270 that includes a split 272 along a portion of its length. The split longitudinally divides the septum into approximately two halves or other multiple portions. The split may terminate near the inner face of the primary seal 172, such that the split 272 travels along at least half of the length of the septum and is joined near the primary seal, but the split may alternatively be any suitable length, including along the entire length of the septum such that the septum includes two separate portions. As shown in FIG. 12C, when the septum 270 is assembled into the catheter hub 120, the channel of the catheter hub preferably radially compresses the septum material to close the split, thereby forming the cavity 176 and the secondary seal 174. The split septum may be manufactured through injection molding, such as with a mold having a cavity complementary to the septum shape as shown in FIG. 12B. In another example of this variation, the split may begin at the inner primary seal and continue towards the secondary seal. In yet another example of this variation, the septum may be split longitudinally along two or more lines, forming three or more split portions.


In a second alternative variation, as shown in FIGS. 13A and 13B, the septum is a dual grommet septum 370 that includes at least two septum pieces 372 or “grommets” placed serially within the catheter hub 120. One of the septum pieces forms the primary seal 172 and another septum piece forms the secondary seal 174. The septum pieces 372 are preferably immediately adjacent to each other such that part of their interior faces are contacting and form a fluid-tight seal against the catheter hub wall. The interior faces of the septum pieces 372 may be chamfered or radiused to define the septum cavity 176 between the septum pieces, but the septum pieces may alternatively have any suitable geometry. Alternatively, the septum pieces may be separated by a distance, such that the septum cavity is at least partially formed by the walls of the catheter hub 120. In other examples of this variation, the septum may include three or more septum pieces placed serially within the catheter hub 120, such as to provide three or more seals.


In a third alternative variation, as shown in FIGS. 14A and 14B, the septum 470 includes at least two separate septum pieces 472 and an inner sleeve 474 disposed between the septum pieces. In this variation, two septum pieces are placed serially within the catheter hub 120, either directly adjacent to each other or separated by a distance. One of the septum pieces forms the primary seal 172 and another septum piece forms the secondary seal 174. The interior faces of the septum pieces 472 are preferably adapted to receive the inner sleeve 474, such as by defining axially aligned recesses. The inner sleeve 474 may be cylindrical and sized to fit within the recesses of the septum pieces, with an inner diameter large enough to form a cavity 176 that accommodates the diameter of the needle 104. The inner sleeve 474 is preferably rigid, and made of a thermoplastic material or any other suitable rigid material, although the inner sleeve may be made of any suitable material. In other examples of this variation, the septum may include more than two septum pieces, such as further including an outer sleeve-like septum part surrounding the inner sleeve.


In a fourth alternative variation, as shown in FIGS. 15A-15E, the septum 570 includes a housing with first and second housing portions 574 and first and second septum pieces 572. In this variation, as shown in FIG. 15E, the septum includes a distal half and a proximal half that is substantially a mirrored version of the distal half, with each half including a housing portion 574 and a corresponding septum piece 572. As shown in FIGS. 15A and 15B, each housing piece includes a tapered, hourglass-shaped chamber 576 for receiving a corresponding septum piece. The taper in the chamber 576 helps reduce relative movement such as translational movement between the septum piece 572 and the housing 574. Each housing piece may further include an external annular flange 578 or other protrusion that helps reduce translational movement between the housing and the catheter hub 120. The two housing pieces 574 may be coupled together and/or to the catheter hub 120 through ultrasonic welding, epoxy or other adhesive, threads, and/or any suitable coupling mechanism. As shown in FIG. 15C and 15D, each septum piece 572 preferably includes a cavity 573 that extends inward from one open end of the septum piece, and the septum pieces are preferably assembled such that the open ends of the septum pieces abut against each other. In this manner, the closed ends of the septum pieces form primary and secondary seals 172 and 174, respectively, of the septum 570, and the joined open ends of the septum pieces form enclosed septum cavity 176. The housing and septum pieces are preferably combined, with a corresponding septum portion nested within (e.g. molded into or pressed into) each housing portion, and the combined housing and septum pieces are preferably mounted within the catheter hub 120.


In an alternative embodiment, the septum may have only a primary seal. In a first alternative variation of this embodiment, the septum 170 is made of a flexible material that self-seals to form a hermetic seal on the hub. This self-sealing septum prevents fluid from passing out of the catheter hub 120, contributing to a closed system in which blood and other fluids will not exit the catheter hub. In a second alternative variation, as shown in FIGS. 16 and 17, the septum 170 may be sealed with a plug, such as a stopper or sealant material applied to the septum by a user. Before and during catheter insertion the back end of the channel of the catheter hub may be left open (FIGS. 16A and 17A). After the catheter is inserted in the patient, the user may occlude the blood vessel (such as by applying external direct pressure), withdraw the needle 104 from the catheter and catheter hub 120, place a plug on the back end of the catheter hub 120 to prevent fluid flow out of the hub (FIGS. 16B and 17B), and allow the blood vessel to be in fluid communication with the catheter (such as by releasing external direct pressure on the blood vessel). The plug may include a separate stopped plug applied to the catheter hub (FIG. 16), a sliding piece that the user slides to gate off the back of the hub (FIG. 17), a hinged piece that the user swings to the back of the hub, and/or any suitable septum piece. Any of these single seal variations of the septum may be repeated serially to form two seals (primary and secondary) or more seals.


The septum may be one or more of the embodiments and variations described above, and/or one or more of the embodiments described in U.S. Provisional Applications 61/346,292 filed 19 May 2010 and 61/407,797 filed 28 Oct. 2010, which is each incorporated in its entirety by this reference. Furthermore, the septum may be any suitable mechanism that helps prevent escape or leakage of fluid from the catheter hub 120.


Integrated Vascular Delivery System—Needle Shield


As shown in FIGS. 18-23, the catheter hub 120 and/or stabilization hub 130 may include a needle shield 190. The needle shield 190 functions to blunt, or protect the user from, the distal end of the needle 104 after the needle is withdrawn from the catheter and catheter hub after catheter insertion. The needle shield 190 helps prevent accidental needle sticks to the user and the transfer of biological hazards. The needle shield 190 is preferably coupled to the catheter hub 120 and/or stabilization hub 130, but may additionally and/or alternatively be coupled to any suitable portion of the system. The needle shield 190 is preferably a clip such as a spring clip, but may alternatively include any suitable blunting mechanism such as a cap. In general, during insertion of the catheter into the patient, the needle 104 passes through an inactive needle shield 190 and into the catheter (e.g., FIG. 18A). After the catheter is placed in the patient, the needle 104 is withdrawn from the catheter in a proximal direction and engages with the needle shield 190, such as due to interaction with a needle catch 106 on the needle 104. After the needle catch 106 engages with the needle shield, the needle shield is triggered to decouple from the catheter hub and/or stabilization hub and cover or blunt the distal end of the needle (e.g., FIG. 18B). The now active needle shield 190 continues to cover the distal end of the needle 104 as the needle is further withdrawn and removed from the catheter hub 120. The needle catch 106 that triggers decoupling of the needle shield 190 from the hub may be one or more of several variations. In one variation, the needle catch 106 may be an annular structure around the needle body that catches on a portion of the needle shield 190 as the needle is withdrawn from the hub. In another variation, the needle catch 106 may include barbs that allow free passage of the needle through the needle shield 190 when the needle passes into the catheter hub 120, but catch on the needle shield 190 when the needle withdraws from the catheter hub 120. Alternatively, the needle catch 106 may be located on the needle shield 190. However, any suitable variation of the needle catch 106 that facilitates the engagement of the needle and the needle shield 190, and the disengagement of the needle shield from the hub, may be used.


The needle shield 190 may be configured in one or more of several arrangements. In a first embodiment, the needle shield 190 is coupled to the catheter hub 120. In a first variation of this first embodiment, the needle shield is removably coupled to an internal portion of the catheter hub 120. For example, the needle shield 190 may be coupled to an internal surface of a proximal portion of the catheter hub 120 (FIGS. 18 and 20), a distal portion of the catheter hub 120 or any suitable internal surface of the catheter hub. As shown in FIG. 18, the needle shield 190 may be coupled to an internal surface of the catheter hub recessed within the catheter hub, or as shown in FIG. 20, the needle shield 190 may be coupled to an internal surface of the catheter hub approximately flush with an external surface of the catheter hub, such as adjacent to the stabilization hub when the frame is in the folded configuration. As another example, the needle shield 190 may be engaged within the catheter hub 120 proximal to the septum 170 (FIG. 19A), and/or distal to the septum 170. As another example, the needle shield is engaged within the septum 170 of the catheter hub (FIG. 19B), such as within the cavity, a slit, or other suitable receptacle within the septum. As yet another example, the needle shield 190 may be adjacent to a flash chamber 192.


In a second variation of the first embodiment, the needle shield 190 is removably coupled to an external portion of the catheter hub 120. For example, as shown in FIGS. 21A and 21B, the needle shield may interact with the catheter hub 120 and/or the needle 104 at least three points. The needle shield may couple to the catheter hub 120 at a first point a, such as to the outside of the hub (e.g., FIG. 21A) or to notches or other receiving features on the proximal portion of the catheter hub 120 (e.g., FIG. 21B). The needle shield 190 closes around the distal end of the needle 104 at a second point b. The withdrawal of the needle 104 causes disengagement of the needle shield from the catheter hub when needle catch 106 engages the needle shield 190 at a third point c. In this example, the needle shield may be a spring clip configured such that when the needle catch 106 on the needle 104 engages with the needle shield during withdrawal, the engagement simultaneously triggers containment of the needle tip at point b and the disengagement of the needle shield from the catheter hub. The spring clip is preferably dimensioned relative to the needle such that a distance “x”, defined as the distance between the distal end of the needle 104 and the needle catch 106, is approximately equal to or less than distance “y”, defined as the distance between points b and c, although the spring clip may have any suitable geometry. However, the needle shield may be any suitable mechanism to blunt the needle tip outside the catheter hub.


In a second embodiment, the needle shield 190 is coupled to the stabilization hub 130. In a first variation of this embodiment, as shown in FIGS. 22A and 22B, the needle shield is removably coupled to an internal portion of the stabilization hub, in a manner similar to that of the first embodiment. For example, the stabilization hub may include a tab that substantially aligns with the catheter hub 120 when the frame 110 is in the folded configuration. The tab may define a recess to which an internal needle shield couples, or an external needle shield may be externally coupled to the tab. During catheter placement, the frame 110 is preferably in the folded configuration and the needle 104 passes through the tab, through the needle shield, and through the catheter hub 120. Upon removal of the needle 104 from the catheter hub 120, the needle shield disengages from the stabilization hub 130 and covers the needle. Following withdrawal of the needle from the catheter hub and disengagement of the needle shield from the stabilization hub, the frame 110 may be unfolded into its unfolded configuration. In a second variation, the needle shield 190 is removably coupled to an external portion of the stabilization hub, particularly when the frame 110 is in the folded configuration, similar to the variation in which the needle shield is coupled to an external portion of the catheter hub.


Additional alternative embodiments of the needle shield include various combinations of the above variations of the needle shield. In other words, the needle shield may be inside and/or outside the catheter hub 120 and/or stabilization hub. For example, as shown in FIG. 23, the needle shield 190 may be coupled directly to an internal portion of the catheter hub 120 and indirectly to an external portion of stabilization hub 130. As another example, the needle shield may be partially inside and partially outside the catheter hub, or the three-point contact needle shield of the first embodiment may be coupled to the stabilization hub instead of the catheter hub 120. Further, the needle shield of any of these variations may be coupled to a sheath that covers at least a portion of the needle body, such that the needle blunter and sheath combination contains more than solely the distal end of the needle.


The needle shield may be one or more of the embodiments and variations described above, and/or one or more of the embodiments described in U.S. Provisional Applications 61/418,358 filed 30 Nov. 2010, 61/438,782 filed 2 Feb. 2011, and 61/448,318 filed 2 Mar. 2011, which are each incorporated in its entirety by this reference. Furthermore, the needle shield may be any suitable mechanism that sufficiently covers and/or blunts the distal end of the needle.


Method for Using an Integrated Vascular Delivery System


As shown in FIGS. 24-27, a method 200 for using an integrated vascular delivery system on a patient includes the steps of: providing a frame S210, wherein the frame includes a catheter hub that receives a catheter, and a stabilization hub; folding the catheter hub and stabilization hub towards one another S220, thereby folding the frame into a folded configuration; coupling the catheter hub and stabilization hub to one another S222; inserting the catheter into the patient at an insertion site S230; unfolding the frame such that the frame surrounds the insertion site S234 in an unfolded configuration S250; and securing the frame to the patient at a plurality of anchoring points distributed around the insertion site S260, thereby stabilizing the catheter relative to the insertion site.


As shown in FIG. 24A, the step of providing a frame S210 preferably includes providing an integrated vascular delivery system similar to that described above, although any suitable frame with a catheter hub and stabilization hub may be used. For example, a suitable integrated vascular delivery system may include a frame with a catheter hub and a stabilization hub coupled together with a hinged joint. Furthermore, the integrated vascular delivery system may include fewer hubs.


The step of folding the catheter hub and stabilization hub towards one another S220 functions to expose the end of the catheter, which may help provide visual and/or physical clearance for the catheter to be positioned at an insertion site. As shown in FIG. 24B, folding the catheter hub and stabilization hub towards one another thereby folds the frame into a folded configuration. The folding step S220 may include passing the stabilization hub towards a relatively stationary catheter hub, passing the catheter hub towards a relatively stationary stabilization hub, or simultaneously passing both the catheter and stabilization hubs towards each other. In one example of the folding step S220, the stabilization hub is positioned to be a proximal portion of the frame (relative to the patient) and the catheter hub is positioned to be a distal portion of the frame. Relative to an insertion site on the forearm of a patient, the stabilization hub is closer to the elbow and the catheter hub is closer to the hand. In this example, the folding step S220 folds the stabilization hub away from the patient towards the catheter hub. Alternatively, the frame may be folded and/or the needle may be inserted into the catheter prior to use such as during manufacturing (e.g. during assembly or packaging). In alternative embodiments, the catheter hub and stabilization hub may be moved in any suitable relative motion, such as sliding or twisting relative to each other.


The step of coupling the catheter hub and stabilization hub to one another S222 functions to secure the frame in the folded configuration. As shown in FIG. 24B, coupling the catheter hub and stabilization hub S222 may include inserting a portion of one of the catheter and stabilization hubs into the other of the catheter and stabilization hubs. For example, inserting a portion of one of the hubs may include inserting an extension of at least one of the hubs into a slot or other recess of another hub. However, in other variations, coupling the catheter hub and stabilization hub may include engaging the hubs in a slidable manner, activating a latch, or any suitable coupling mechanism.


Inserting the catheter into the patient at an insertion site S230 functions to establish a conduit through which fluid can be administered to or transferred from the patient. As shown in FIG. 24C-E, inserting the catheter S230 preferably includes inserting a needle into the catheter hub, passing the needle telescopically through the catheter, penetrating the insertion site with the needle, positioning the catheter within the insertion site S234, and withdrawing the needle from the catheter S236. In one variation, inserting the needle into the catheter hub includes passing the needle through the extension S232 (the extension of one of the hubs received by another hub in step S222), thereby locking the catheter and stabilization hubs.


In one variation, as shown in FIGS. 25A-D, inserting the catheter S230 may further include engaging at least a distal portion of the needle with a needle shield S240 coupled to the catheter hub and/or stabilization hub. The needle shield preferably functions to cover the distal end of the needle and may a spring clip, cap, or any suitable mechanism. The needle shield may be inside or outside the catheter hub, inside or outside the stabilization hub, or coupled to any suitable part of the frame. In this variation, inserting the catheter may further include decoupling the needle shield S242 from the catheter hub and/or stabilization hub before, simultaneously with, or after, withdrawing the needle from the catheter hub S236. The action of the needle insertion and/or needle withdrawal may trigger the decoupling of the needle shield from the catheter hub and/or stabilization hub. In this manner, the needle may be fully withdrawn from the catheter hub while still being engaged and/or covered with the needle shield.


Unfolding the frame S250 functions to orient the frame around the insertion site in an unfolded configuration. As shown in FIG. 24F, unfolding the frame S250 preferably reverses the movement performed on the catheter hub and stabilization hub in the step of folding the frame S220, but may additionally and/or alternatively include other suitable steps such as moving the catheter hub and stabilization hub in another direction, twisting a portion of the frame, or sliding a portion of the frame.


Securing the frame to the patient S260 at a plurality of anchoring points distributed around the insertion site functions to stabilize the frame, and thereby the catheter, relative to the insertion site. Securing the frame includes securing the catheter hub at a first anchoring point and securing the stabilization hub at a second anchoring point. As shown in FIGS. 24G and 26, the first and second anchoring points are distributed around the insertion site, preferably on substantially opposite sides of the insertion site. More preferably, as shown in FIG. 27, one of the anchoring points is proximal to the insertion site and another anchoring point is distal to the insertion site. However, the first and second anchoring points may be distributed around the insertion site in any suitable manner. In one variation, securing the frame may further include securing the frame at a third anchoring point, such that the first, second and third anchoring points are distributed around the insertion site. The frame may also be secured to the patient at four or more anchoring points. The multiple anchoring points may be approximately equally or unequally distributed around the insertion site. The securing steps may include taping the frame to the patient (e.g. with medical tape or sterile adhesive dressing), adhering the frame to the patient with adhesive, strapping the frame to the patient, or any suitable securing mechanism.


As shown in FIG. 24G, the method may further include applying a septum plug S270, preferably to a proximal portion (e.g. needle-receiving channel) of the catheter hub, which functions to help prevent escape or leakage of fluids from the catheter after the catheter insertion. The septum plug may be applied in one or more several manners depending on the nature of the plug, and applying a septum plug S270 may include sliding a septum plug over the catheter hub (e.g. septum is a sliding gate), stopping a channel in the catheter hub (e.g. septum is a stopper), or any suitable steps.


As shown in FIG. 26, the method may further include the step of applying a dressing over the insertion site and the frame S280. The step of applying a dressing functions to protect the insertion site against bacteria, viruses, and other pathogens. The dressing is preferably a breathable, sterile dressing. The dressing is preferably transparent to allow visualization of the insertion site, and includes adhesive to attach to the skin of the patient and to provide securement of the frame. The dressing can be used after the frame has been secured to the patient, or the dressing can be used to secure the frame to the patient. However, the dressing can include any suitable device or method to assist in the protection of the insertion site.


As a person skilled in the art will recognize from the previous detailed description and from the figures and claims, modifications and changes can be made to the preferred embodiments of the invention without departing from the scope of this invention defined in the following claims.

Claims
  • 1. An integrated vascular delivery system adapted to facilitate insertion of a catheter into a patient at an insertion site, comprising: a frame including: a catheter hub coupled to the catheter,a stabilization hub,a first flexible lateral member defining a lumen and extending from a distal region of the catheter hub to a proximal region of the stabilization hub,a fluidic channel configured to pass through the catheter hub, wherein the fluidic channel comprises a fixed turnabout portion defined within the catheter hub, wherein the fixed turnabout portion is configured to direct fluid flow toward the distal region of the catheter hub, anda septum coupled to the catheter hub, wherein the septum is configured to receive a needle to facilitate insertion of the catheter at the insertion site; anda needle shield configured to capture at least a portion of the needle as the needle is withdrawn from the catheter hub.
  • 2. The system of claim 1, wherein the needle shield is coupled to the catheter hub.
  • 3. The system of claim 1, wherein the needle shield is coupled to the stabilization hub.
  • 4. The system of claim 1, wherein the needle shield comprises a cap.
  • 5. The system of claim 1, wherein the needle shield comprises a spring clip.
  • 6. The system of claim 5, wherein at least a portion of the spring clip is positioned proximal of the catheter hub, and wherein the spring clip is configured to capture at least a tip of the needle.
  • 7. The system of claim 5, wherein the spring clip is configured to be coupled to an outer region of the catheter hub.
  • 8. The system of claim 5, wherein the catheter hub further comprises a receiving feature, and wherein the spring clip is configured to be coupled to the receiving feature.
  • 9. The system of claim 1, wherein the needle shield allows the needle to penetrate the catheter, through the needle shield, in an inactive configuration, and covers a distal end of the needle in an active configuration, in withdrawing of the needle from the catheter.
  • 10. The system of claim 9, wherein the needle shield is removably coupled to the catheter hub, and configured to engage a needle catch, upon withdrawal of the needle from the catheter hub, that transitions the needle shield from the inactive configuration to the active configuration.
  • 11. The system of claim 10, wherein the needle catch comprises an annular structure disposed around the needle, and wherein the needle catch is configured to engage a portion of the needle shield upon withdrawal of the needle from the catheter hub.
  • 12. The system of claim 10, wherein the needle catch comprises barbs configured to allow the needle to penetrate the catheter hub through the needle shield and to catch the needle shield upon withdrawal of the needle from the catheter hub.
  • 13. The system of claim 1, wherein the needle shield comprises a needle catch.
  • 14. The system of claim 1, wherein the septum is configured to direct the needle into a portion of the fixed turnabout portion and into the catheter.
  • 15. The system of claim 1, wherein the stabilization hub is retained in an angularly displaced position relative to the catheter hub.
  • 16. The system of claim 1, wherein the fluidic channel is configured to direct fluid flow into the fixed turnabout portion.
  • 17. The system of claim 1, wherein the catheter hub provides a first anchoring point on the patient and the stabilization hub provides a second anchoring point on the patient.
INCORPORATION BY REFERENCE TO ANY PRIORITY APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/821,680, filed 22 Nov. 2017, which is a continuation of U.S. patent application Ser. No. 14/267,811, filed 1 May 2014, now U.S. Pat. No. 9,827,398, which is a continuation of U.S. patent application Ser. No. 13/111,693, filed 19 May 2011, now U.S. Pat. No. 8,771,230, which claims the benefit of U.S. Provisional Application No. 61/356,776, filed 21 Jun. 2010, U.S. Provisional Application No. 61/346,292, filed 19 May 2010, U.S. Provisional Application No. 61/407,797, filed 28 Oct. 2010, U.S. Provisional Application No. 61/418,349, filed 30 Nov. 2010, U.S. Provisional Application No. 61/438,774, filed 2 Feb. 2011, U.S. Provisional Application No. 61/418,358, filed 30 Nov. 2010, U.S. Provisional Application No. 61/438,782, filed 2 Feb. 2011, and U.S. Provisional Application No. 61/448,318, filed 2 Mar. 2011, all of which are incorporated in their entirety by this reference.

US Referenced Citations (823)
Number Name Date Kind
2868200 Gewecke Jan 1959 A
3561429 Jewett Feb 1971 A
3729031 Baldwin Apr 1973 A
4013080 Froning Mar 1977 A
4160450 Doherty Jul 1979 A
4316461 Marais et al. Feb 1982 A
4380234 Kamen Apr 1983 A
4397641 Jacobs Aug 1983 A
4424833 Spector et al. Jan 1984 A
4430073 Bemis et al. Feb 1984 A
4432752 Marlon Feb 1984 A
4435173 Siposs et al. Mar 1984 A
4436519 O'Neill Mar 1984 A
4576589 Kraus et al. Mar 1986 A
4591356 Christie May 1986 A
4605011 Näslund Aug 1986 A
4681567 Masters et al. Jul 1987 A
4695274 Fox Sep 1987 A
4755170 Golden Jul 1988 A
4776841 Catalano Oct 1988 A
4798594 Hillstead Jan 1989 A
4799494 Wang Jan 1989 A
4801295 Spencer Jan 1989 A
4834271 Litwin May 1989 A
4834718 McDonald May 1989 A
4846796 Carrell et al. Jul 1989 A
4890626 Wang Jan 1990 A
4898587 Mera Feb 1990 A
4909798 Fleischhacker et al. Mar 1990 A
4935010 Cox et al. Jun 1990 A
4936830 Verlier Jun 1990 A
4941883 Venturini Jul 1990 A
4944725 McDonald Jul 1990 A
4944728 Carrell et al. Jul 1990 A
4952207 Lemieux Aug 1990 A
4964854 Luther Oct 1990 A
4976698 Stokley Dec 1990 A
5000740 Ducharme et al. Mar 1991 A
5049136 Johnson Sep 1991 A
5084023 Lemieux Jan 1992 A
5084026 Shapiro Jan 1992 A
5085648 Purdy et al. Feb 1992 A
5092845 Chang Mar 1992 A
5098048 Chen Mar 1992 A
5116324 Brierley et al. May 1992 A
5129884 Dysarz Jul 1992 A
5135504 Mclees Aug 1992 A
5147327 Johnson Sep 1992 A
5147333 Raines Sep 1992 A
5147375 Sullivan et al. Sep 1992 A
5171234 Jepson et al. Dec 1992 A
5192275 Burns Mar 1993 A
5199948 McPhee Apr 1993 A
5201717 Wyatt et al. Apr 1993 A
5207647 Phelps May 1993 A
5211634 Vaillancourt May 1993 A
5215525 Sturman Jun 1993 A
5215528 Purdy et al. Jun 1993 A
5215537 Lynn et al. Jun 1993 A
5232010 Rozenblatt et al. Aug 1993 A
5238010 Grabenkort et al. Aug 1993 A
5254097 Schock et al. Oct 1993 A
5269771 Thomas et al. Dec 1993 A
5295970 Clinton et al. Mar 1994 A
5295977 Cohen et al. Mar 1994 A
5300034 Behnke et al. Apr 1994 A
5312368 Haynes May 1994 A
5314411 Bierman et al. May 1994 A
5351383 Behnke et al. May 1994 A
5330438 Gollobin et al. Jul 1994 A
5352205 Dales et al. Oct 1994 A
5354275 Behnke et al. Oct 1994 A
5354282 Bierman Oct 1994 A
5356390 Erskine Oct 1994 A
5360408 Vaillancourt Nov 1994 A
5364368 Kauffman et al. Nov 1994 A
5368801 Vaillancourt Nov 1994 A
5375589 Bhatta Dec 1994 A
5376071 Henderson Dec 1994 A
5376082 Phelps Dec 1994 A
5400500 Behnke et al. Mar 1995 A
5405331 Behnke et al. Apr 1995 A
5413562 Swauger May 1995 A
5425465 Healy Jun 1995 A
5425721 Malenchek Jun 1995 A
5439451 Collinson et al. Aug 1995 A
5445623 Richmond Aug 1995 A
5456668 Ogle, II Oct 1995 A
5458658 Sircom Oct 1995 A
5462255 Rosen et al. Oct 1995 A
5472430 Vaillancourt et al. Dec 1995 A
5474544 Lynn Dec 1995 A
5476452 Thompson Dec 1995 A
5487728 Vaillancourt Jan 1996 A
5487734 Thorne et al. Jan 1996 A
5498247 Brimhall Mar 1996 A
5501674 Trombley, III et al. Mar 1996 A
5509912 Vaillancourt et al. Apr 1996 A
5514111 Phelps May 1996 A
5514116 Vaillancourt et al. May 1996 A
5522804 Lynn Jun 1996 A
5545146 Ishak Aug 1996 A
5549651 Lynn Aug 1996 A
5558651 Crawford et al. Sep 1996 A
5562631 Bogert Oct 1996 A
5575769 Vaillancourt Nov 1996 A
5575777 Cover et al. Nov 1996 A
5591138 Vaillancourt Jan 1997 A
5601536 Crawford et al. Feb 1997 A
5643216 White Jul 1997 A
5669891 Vaillancourt Sep 1997 A
5676656 Brimhall Oct 1997 A
5676658 Erskine Oct 1997 A
5688253 Paradis Nov 1997 A
5697914 Brimhall Dec 1997 A
5697915 Lynn Dec 1997 A
5702367 Cover et al. Dec 1997 A
5702371 Bierman Dec 1997 A
5704914 Stocking et al. Jan 1998 A
5713876 Bogert et al. Feb 1998 A
5725499 Silverstein et al. Mar 1998 A
5727770 Dennis Mar 1998 A
5735826 Richmond Apr 1998 A
5735827 Adwers et al. Apr 1998 A
5740810 Johnson et al. Apr 1998 A
5743884 Hasson et al. Apr 1998 A
5746727 Graves et al. May 1998 A
5749857 Cuppy May 1998 A
5755709 Cuppy May 1998 A
5769825 Lynn Jun 1998 A
5788675 Mayer Aug 1998 A
5810780 Brimhall Sep 1998 A
5827221 Phelps Oct 1998 A
5830184 Basta Nov 1998 A
5833662 Stevens Nov 1998 A
5846227 Osterlind Dec 1998 A
5879330 Bell Mar 1999 A
5902274 Yamamoto et al. May 1999 A
5911705 Howell Jun 1999 A
5913845 Brimhall Jun 1999 A
5916199 Miles Jun 1999 A
5935110 Brimhall Aug 1999 A
5954698 Pike Sep 1999 A
5957887 Oesterlind et al. Sep 1999 A
5989220 Shaw et al. Nov 1999 A
5997504 Bell Dec 1999 A
6001080 Kuracina et al. Dec 1999 A
6004294 Brimhall et al. Dec 1999 A
6022339 Fowles et al. Feb 2000 A
6027480 Davis et al. Feb 2000 A
6033382 Basta Mar 2000 A
6056718 Funerburk et al. May 2000 A
6077244 Botich et al. Jun 2000 A
6077248 Zumschlinge Jun 2000 A
6086564 McLaughlin Jul 2000 A
6142981 Heck et al. Nov 2000 A
6149632 Landuyt Nov 2000 A
6152913 Feith et al. Nov 2000 A
6162206 Bindokas et al. Dec 2000 A
6168137 Paradis Jan 2001 B1
6171287 Lynn et al. Jan 2001 B1
6197007 Thorne et al. Mar 2001 B1
6210624 Mayer Apr 2001 B1
6213978 Voyten Apr 2001 B1
6221048 Phelps Apr 2001 B1
6228065 Lynn May 2001 B1
6261259 Bell Jul 2001 B1
6261268 Mayer Jul 2001 B1
6273869 Vaillancourt Aug 2001 B1
6273871 Davis et al. Aug 2001 B1
RE37357 Lynn Sep 2001 E
6299602 Miller et al. Oct 2001 B1
6302866 Marggi Oct 2001 B1
6342120 Basta Jan 2002 B1
6375639 Duplessie et al. Apr 2002 B1
6379333 Brimhall et al. Apr 2002 B1
6379337 Mohammad Apr 2002 B1
6443929 Kuracina et al. Sep 2002 B1
6506181 Meng et al. Jan 2003 B2
6520938 Funderburk et al. Feb 2003 B1
6569120 Green et al. May 2003 B1
RE38145 Lynn Jun 2003 E
6572586 Wojcik Jun 2003 B1
6572588 Bierman Jun 2003 B1
6572591 Mayer Jun 2003 B2
6595955 Ferguson et al. Jul 2003 B2
6623461 Wilkinson et al. Sep 2003 B1
6638252 Moulton et al. Oct 2003 B2
6652490 Howell Nov 2003 B2
6663599 Osborne et al. Dec 2003 B2
6673046 Bierman et al. Jan 2004 B2
6692468 Waldenburg Feb 2004 B1
6699221 Vaillancourt Mar 2004 B2
6712790 Prestidge et al. Mar 2004 B1
6719726 Meng et al. Apr 2004 B2
6719727 Brimhall et al. Apr 2004 B2
6730096 Basta May 2004 B2
6740277 Howell et al. May 2004 B2
6749588 Howell et al. Jun 2004 B1
6761706 Vaillancourt Jul 2004 B2
6776775 Mohammad Aug 2004 B1
6805860 Alt Oct 2004 B1
6811545 Vaillancourt Nov 2004 B2
6832994 Niedospial, Jr. et al. Dec 2004 B2
6837875 Bierman Jan 2005 B1
6849051 Sramek et al. Feb 2005 B2
6902546 Ferguson Jun 2005 B2
6905483 Newby et al. Jun 2005 B2
6908459 Harding et al. Jun 2005 B2
6921391 Barker et al. Jul 2005 B1
6926721 Basta Aug 2005 B2
6953448 Moulton et al. Oct 2005 B2
6955659 Carter Oct 2005 B1
6972002 Thorne Dec 2005 B2
6981965 Luther et al. Jan 2006 B2
6981966 Green et al. Jan 2006 B2
6984223 Newby et al. Jan 2006 B2
RE38996 Crawford et al. Feb 2006 E
6997902 Thorne et al. Feb 2006 B2
6997913 Wilkinson Feb 2006 B2
6997917 Niedospial, Jr. et al. Feb 2006 B2
7004934 Vaillancourt Feb 2006 B2
7008406 Mayer Mar 2006 B2
7022111 Duplessie et al. Apr 2006 B2
7033339 Lynn Apr 2006 B1
7060055 Wilkinson et al. Jun 2006 B2
7060060 Simpson et al. Jun 2006 B1
7090660 Roberts et al. Aug 2006 B2
7090661 Morris et al. Aug 2006 B2
7112191 Daga Sep 2006 B2
RE39334 Lynn Oct 2006 E
7125398 Garcia, Jr. Oct 2006 B2
7141040 Lichtenberg Nov 2006 B2
7147622 Gutierrez Dec 2006 B2
7220249 Hwang et al. May 2007 B2
7258680 Mogensen et al. Aug 2007 B2
7344516 Erskine Mar 2008 B2
7347842 Thorne et al. Mar 2008 B2
7351230 Smith et al. Apr 2008 B2
7354422 Riesenberger et al. Apr 2008 B2
7396346 Nakajima Jul 2008 B2
7413562 Ferguson et al. Aug 2008 B2
7435238 Reid Oct 2008 B2
7445611 Osborne et al. Nov 2008 B2
7470261 Lynn Dec 2008 B2
7481797 Mahurkar Jan 2009 B2
7507222 Cindrich et al. Mar 2009 B2
7569033 Greene et al. Aug 2009 B2
7604616 Thoresen et al. Oct 2009 B2
7611499 Woehr et al. Nov 2009 B2
7615033 Leong Nov 2009 B2
7618395 Ferguson Nov 2009 B2
7625360 Woehr et al. Dec 2009 B2
7635357 Mayer Dec 2009 B2
7651481 Raybuck Jan 2010 B2
7654988 Moulton et al. Feb 2010 B2
7658725 Bialecki et al. Feb 2010 B2
7666166 Emmert et al. Feb 2010 B1
7670299 Beckman et al. Mar 2010 B2
7670317 Cindrich et al. Mar 2010 B2
7682339 Fujii Mar 2010 B2
7694403 Moulton Apr 2010 B2
7699814 Lande Apr 2010 B2
7713243 Hillman May 2010 B2
7713250 Harding et al. May 2010 B2
7717882 Harding May 2010 B2
7722569 Söederholm et al. May 2010 B2
7736332 Carlyon et al. Jun 2010 B2
7736337 Diep et al. Jun 2010 B2
7736342 Abriles et al. Jun 2010 B2
7740615 Shaw et al. Jun 2010 B2
7744572 Bierman Jun 2010 B2
7749254 Sobelman et al. Jul 2010 B2
7762993 Perez Jul 2010 B2
7763199 Fangrow, Jr. Jul 2010 B2
7766879 Tan et al. Aug 2010 B2
7766897 Ramsey et al. Aug 2010 B2
7771412 Anderson et al. Aug 2010 B2
7776017 Ponzi et al. Aug 2010 B2
7798991 Insignares Sep 2010 B2
7798994 Brimhall Sep 2010 B2
7799000 Silich Sep 2010 B2
7806869 Nilsson et al. Oct 2010 B2
7833201 Carlyon et al. Nov 2010 B2
7862547 Ferguson et al. Jan 2011 B2
7887515 Bierman Feb 2011 B2
7892216 Fangrow, Jr. Feb 2011 B2
7918828 Lundgaard et al. Apr 2011 B2
7931615 Fangrow, Jr. Apr 2011 B2
7959613 Rhad et al. Jun 2011 B2
7972313 Woehr et al. Jul 2011 B2
7998134 Fangrow et al. Aug 2011 B2
8012145 Cawley Sep 2011 B2
8025644 Chong et al. Sep 2011 B2
8042689 Fröjd et al. Oct 2011 B2
8043265 Abe et al. Oct 2011 B2
8048031 Shaw et al. Nov 2011 B2
8062262 Christensen et al. Nov 2011 B2
8066669 Christensen et al. Nov 2011 B2
8066670 Cluff et al. Nov 2011 B2
8066675 Cindrich et al. Nov 2011 B2
8066678 Vaillancourt et al. Nov 2011 B2
8070725 Christensen Dec 2011 B2
8079979 Moorehead Dec 2011 B2
8083728 Rome Dec 2011 B2
8092435 Beling et al. Jan 2012 B2
8105286 Anderson et al. Jan 2012 B2
8105288 Keyser et al. Jan 2012 B2
8122923 Kraus et al. Feb 2012 B2
8123738 Vaillancourt Feb 2012 B2
8133202 Marsh Mar 2012 B2
8133206 Greene et al. Mar 2012 B2
8147455 Butts et al. Apr 2012 B2
8147465 Kern Apr 2012 B2
8157770 Elwell et al. Apr 2012 B2
8162882 Rubinstein et al. Apr 2012 B2
8162896 Tan Apr 2012 B2
8162914 Kraushaar et al. Apr 2012 B2
8163237 Crawford et al. Apr 2012 B2
8172803 Morrissey et al. May 2012 B2
8172825 Solomon et al. May 2012 B2
8177745 Brechbuehler et al. May 2012 B2
8177753 Vitullo et al. May 2012 B2
8177754 Barnes May 2012 B2
8177755 Berry et al. May 2012 B2
8177760 Rome et al. May 2012 B2
8177762 Beasley et al. May 2012 B2
8177772 Christensen et al. May 2012 B2
8182448 Emmert et al. May 2012 B2
8197452 Harding et al. Jun 2012 B2
8197466 Yokota et al. Jun 2012 B2
8211070 Woehr et al. Jul 2012 B2
8226612 Nakajima Jul 2012 B2
8251950 Albert et al. Aug 2012 B2
8273056 Kuracina et al. Sep 2012 B2
8277424 Pan Oct 2012 B2
8287518 Kitani et al. Oct 2012 B2
8298195 Peppel Oct 2012 B2
8313459 Kiehne Nov 2012 B2
8313469 Fiser Nov 2012 B2
8323249 White et al. Dec 2012 B2
8337471 Baid Dec 2012 B2
8337483 Harding et al. Dec 2012 B2
8357121 Burkholz Jan 2013 B2
8361408 Lynn Jan 2013 B2
8366676 Harding et al. Feb 2013 B2
8377010 Harding et al. Feb 2013 B2
8377040 Burkholz et al. Feb 2013 B2
8382718 Woehr Feb 2013 B2
8382721 Woehr et al. Feb 2013 B2
8398597 Brimhall Mar 2013 B2
8398598 Carlyon et al. Mar 2013 B2
8403894 Lynn et al. Mar 2013 B2
8403905 Yow Mar 2013 B2
8408226 Raines et al. Apr 2013 B2
8409165 Niedospial, Jr. et al. Apr 2013 B2
8419688 Woehr et al. Apr 2013 B2
8430850 Gyrn et al. Apr 2013 B2
8439877 Burkholz May 2013 B2
8439891 Milligan May 2013 B1
8444605 Kuracina et al. May 2013 B2
8460247 Woehr et al. Jun 2013 B2
8465441 Srivatsa et al. Jun 2013 B2
8511352 Kraus et al. Aug 2013 B2
8529524 Newton et al. Sep 2013 B2
8545454 Kuracina et al. Oct 2013 B2
8556854 Zivkovic et al. Oct 2013 B2
8556855 Zivkovic et al. Oct 2013 B2
8568372 Woehr et al. Oct 2013 B2
8591469 Keyser et al. Nov 2013 B2
8622967 Davis et al. Jan 2014 B2
8628497 Finnestad et al. Jan 2014 B2
8636697 Scheurer et al. Jan 2014 B2
8647301 Bialecki et al. Feb 2014 B2
8652104 Goral et al. Feb 2014 B2
8657788 Fangrow, Jr. Feb 2014 B2
8657790 Tal et al. Feb 2014 B2
8663169 Emmert et al. Mar 2014 B2
8668674 White et al. Mar 2014 B2
8671964 Py Mar 2014 B2
8684994 Lev et al. Apr 2014 B2
8702675 Imai Apr 2014 B2
8715222 Truitt et al. May 2014 B2
8715247 Mansour et al. May 2014 B2
8715250 Tremblay May 2014 B2
8721627 Alpert May 2014 B2
8728035 Warring et al. May 2014 B2
8771230 White et al. Jul 2014 B2
8784387 Woehr Jul 2014 B2
8790310 White et al. Jul 2014 B2
8801678 Panian et al. Aug 2014 B2
8814833 Farrell et al. Aug 2014 B2
8827965 Woehr et al. Sep 2014 B2
8834422 Walker et al. Sep 2014 B2
8834432 Winsor et al. Sep 2014 B2
8840577 Zollinger et al. Sep 2014 B1
8858503 Burkholz et al. Oct 2014 B2
8870835 Baid Oct 2014 B2
8870846 Davis et al. Oct 2014 B2
8876784 Coete, Sr. et al. Nov 2014 B2
8882742 Dikeman et al. Nov 2014 B2
8900192 Anderson et al. Dec 2014 B2
8900199 Kawai et al. Dec 2014 B2
8910919 Bonnal et al. Dec 2014 B2
8915891 Bornhoft Dec 2014 B2
8932259 Stout et al. Jan 2015 B2
8951233 Mansour Feb 2015 B2
8956328 Antonucci Feb 2015 B2
8956330 Fangrow, Jr. Feb 2015 B2
8968252 White et al. Mar 2015 B2
8968261 Kimball et al. Mar 2015 B2
8968271 Guala Mar 2015 B2
8974425 Tachizaki et al. Mar 2015 B2
8979795 Bokelman et al. Mar 2015 B2
8979804 Ho et al. Mar 2015 B2
8986227 Belson Mar 2015 B2
8998851 Constantineau et al. Apr 2015 B2
9011382 Nilsson et al. Apr 2015 B2
9017288 Starnes Apr 2015 B1
9017295 Pan Apr 2015 B2
9032997 Abura et al. May 2015 B2
9033927 Maan et al. May 2015 B2
9033952 Chen May 2015 B2
9039047 Imai May 2015 B2
9044552 Schraga Jun 2015 B2
9044585 Masuda et al. Jun 2015 B2
9050128 Ros Jun 2015 B2
9056188 Hager et al. Jun 2015 B2
9061130 Truitt et al. Jun 2015 B2
9067049 Panian et al. Jun 2015 B2
9089680 Ueda et al. Jul 2015 B2
9089681 Ueda et al. Jul 2015 B2
9089682 Yeh et al. Jul 2015 B2
9095679 Nishimura et al. Aug 2015 B2
9095683 Hall et al. Aug 2015 B2
9114231 Woehr et al. Aug 2015 B2
9114241 Stout et al. Aug 2015 B2
9114244 Yeh et al. Aug 2015 B2
9119950 Mansour et al. Sep 2015 B2
9126017 Albert et al. Sep 2015 B2
9138572 Zeytoonian et al. Sep 2015 B2
9144672 Mansour et al. Sep 2015 B2
9162029 Zollinger Oct 2015 B2
9162037 Belson et al. Oct 2015 B2
9198831 Rogers Dec 2015 B2
9199062 Liska et al. Dec 2015 B2
9199063 Baid Dec 2015 B2
9212772 Ho et al. Dec 2015 B2
9220871 Thörne et al. Dec 2015 B2
9227038 Woehr Jan 2016 B2
9233229 Emmert et al. Jan 2016 B2
9234616 Carrez et al. Jan 2016 B2
9238128 Yamaguchi et al. Jan 2016 B2
9238130 Mouri Jan 2016 B2
9259533 Weilbacher et al. Feb 2016 B2
9259537 Baney et al. Feb 2016 B2
9265882 Ito Feb 2016 B2
9271668 Crawford et al. Mar 2016 B2
9278180 Wong Mar 2016 B2
9278195 Erskine Mar 2016 B2
9278205 Quach et al. Mar 2016 B2
9289237 Woehr et al. Mar 2016 B2
9289588 Chen Mar 2016 B2
9308352 Teoh et al. Apr 2016 B2
9308353 Shaw et al. Apr 2016 B1
9308354 Farrell et al. Apr 2016 B2
9314604 Bonnal et al. Apr 2016 B2
9320469 Shaw et al. Apr 2016 B2
9320858 Grimm et al. Apr 2016 B2
9320859 Grimm et al. Apr 2016 B2
9320860 Grimm et al. Apr 2016 B2
9345641 Kraus et al. May 2016 B2
9352127 Yeh et al. May 2016 B2
9370466 Garfield et al. Jun 2016 B2
9370641 Woehr et al. Jun 2016 B2
9370651 Zollinger et al. Jun 2016 B2
9375551 Harding Jun 2016 B2
9375552 Tremblay Jun 2016 B2
9381324 Fuchs et al. Jul 2016 B2
9381337 Carter et al. Jul 2016 B2
9393398 Truitt et al. Jul 2016 B2
9399116 Goral et al. Jul 2016 B2
9399119 Kuracina et al. Jul 2016 B2
9399120 Burkholz Jul 2016 B2
9408632 Erskine Aug 2016 B2
9409007 Yeh Aug 2016 B2
9415192 Kuracina et al. Aug 2016 B2
9421345 Woehr et al. Aug 2016 B2
9421352 Butts et al. Aug 2016 B2
9427549 Woehr et al. Aug 2016 B2
9433708 Eddy Sep 2016 B2
9433758 Farley et al. Sep 2016 B2
9522255 Knutsson Dec 2016 B2
9592366 White et al. Mar 2017 B2
9809355 Solomon et al. Nov 2017 B2
9827398 White et al. Nov 2017 B2
9962526 White et al. May 2018 B2
10086170 Chhikara et al. Oct 2018 B2
10159818 Farrell et al. Dec 2018 B2
10569057 White et al. Feb 2020 B2
10668252 White et al. Jun 2020 B2
10814107 Chhikara et al. Oct 2020 B2
10905858 Farrell et al. Feb 2021 B2
20010041871 Brimhall Nov 2001 A1
20020045843 Barker et al. Apr 2002 A1
20020165497 Greene et al. Nov 2002 A1
20020169418 Menzi et al. Nov 2002 A1
20020177814 Meng et al. Nov 2002 A1
20030032922 Moorehead Feb 2003 A1
20030073956 Hoffman et al. Apr 2003 A1
20030083620 Luther et al. May 2003 A1
20030083621 Shaw et al. May 2003 A1
20030120222 Vaillancourt Jun 2003 A1
20030181871 Wilkinson et al. Sep 2003 A1
20030195479 Kuracina et al. Oct 2003 A1
20030199827 Thorne Oct 2003 A1
20040010227 Riesenberger et al. Jan 2004 A1
20040106903 Shue et al. Jan 2004 A1
20040030294 Mahurkar Feb 2004 A1
20040064102 Yamada Apr 2004 A1
20040097888 Gutierrez May 2004 A1
20040102735 Moulton May 2004 A1
20040111059 Howlett et al. Jun 2004 A1
20040116855 Popov et al. Jun 2004 A1
20040127856 Johnson Jul 2004 A1
20040143216 Douglas et al. Jul 2004 A1
20040181192 Cuppy Sep 2004 A1
20040206416 Paradis Oct 2004 A1
20040267210 Popovsky Dec 2004 A1
20050027263 Woehr et al. Feb 2005 A1
20050043709 Brimhall et al. Feb 2005 A1
20050045192 Fulton et al. Mar 2005 A1
20050059933 Johnson Mar 2005 A1
20050113755 Greene et al. May 2005 A1
20050131350 Shaw et al. Jun 2005 A1
20050192535 Takagi et al. Sep 2005 A1
20060015071 Fitzgerald Jan 2006 A1
20060015075 Blanco et al. Jan 2006 A1
20060030815 Csincsura et al. Feb 2006 A1
20060060892 Propp Mar 2006 A1
20060094983 Burbank et al. May 2006 A1
20060106335 Putter et al. May 2006 A1
20060116638 Woehr et al. Jun 2006 A1
20060155258 Rogers et al. Jul 2006 A1
20060189942 Chang et al. Aug 2006 A1
20060247577 Wright Nov 2006 A1
20060253076 Butts et al. Nov 2006 A1
20060264833 Moulton Nov 2006 A1
20060270994 Bierman Nov 2006 A1
20070016149 Hunn et al. Jan 2007 A1
20070038179 Bialecki et al. Feb 2007 A1
20070038182 Bialecki et al. Feb 2007 A1
20070038183 Bialecki et al. Feb 2007 A1
20070038185 Albert et al. Feb 2007 A1
20070038186 Sutton et al. Feb 2007 A1
20070038187 Albert et al. Feb 2007 A1
20070060892 Propp Mar 2007 A1
20070066958 Wright Mar 2007 A1
20070066960 Jones et al. Mar 2007 A1
20070073221 Bialecki et al. Mar 2007 A1
20070078400 Gesler, III Apr 2007 A1
20070079894 Kraus et al. Apr 2007 A1
20070129689 Woehr et al. Jun 2007 A1
20070142785 Lundgaard et al. Jun 2007 A1
20070161950 Carlyon et al. Jul 2007 A1
20070173768 Bierman Jul 2007 A2
20070179446 Carrez et al. Aug 2007 A1
20070185454 Fangrow Aug 2007 A1
20070185455 Fangrow Aug 2007 A1
20070191776 Bialecki et al. Aug 2007 A1
20070191777 King Aug 2007 A1
20070244438 Perez Oct 2007 A1
20070250011 Lee Oct 2007 A1
20070250057 Nobis et al. Oct 2007 A1
20070255212 Smith et al. Nov 2007 A1
20070265572 Smith et al. Nov 2007 A1
20070270754 Soderholm et al. Nov 2007 A1
20070270758 Hanner et al. Nov 2007 A1
20080039796 Nakajima Feb 2008 A1
20080051726 Lee et al. Feb 2008 A1
20080097315 Miner et al. Apr 2008 A1
20080108944 Woehr et al. May 2008 A1
20080125717 Shue et al. May 2008 A1
20080132846 Shue et al. Jun 2008 A1
20080135443 Frojd et al. Jun 2008 A1
20080140004 Thorne et al. Jun 2008 A1
20080140011 Hager et al. Jun 2008 A1
20080147009 Nilsson et al. Jun 2008 A1
20080195033 Eagleson et al. Aug 2008 A1
20080200791 Simpson et al. Aug 2008 A1
20080215009 Shaw et al. Sep 2008 A1
20080228144 Liniger et al. Sep 2008 A1
20080262431 Anderson et al. Oct 2008 A1
20080287876 Shue et al. Nov 2008 A1
20080300543 Abriles et al. Dec 2008 A1
20080300574 Belson et al. Dec 2008 A1
20090012480 Moulton et al. Jan 2009 A1
20090036836 Nystrom et al. Feb 2009 A1
20090036914 Houser Feb 2009 A1
20090043260 Bierman Feb 2009 A1
20090069751 Curtis et al. Mar 2009 A1
20090076435 Melsheimer et al. Mar 2009 A1
20090082732 Hillman Mar 2009 A1
20090082733 Fujii Mar 2009 A1
20090124981 Evans May 2009 A1
20090131870 Fiser May 2009 A1
20090131872 Popov May 2009 A1
20090137958 Erskine May 2009 A1
20090137961 Bracken May 2009 A1
20090163861 Carlyon Jun 2009 A1
20090177167 Kuracina et al. Jul 2009 A1
20090221961 Tal et al. Sep 2009 A1
20090227896 Tan et al. Sep 2009 A1
20090299295 Rubinstein et al. Dec 2009 A1
20090306602 Elwell et al. Dec 2009 A1
20100004604 Stearns Jan 2010 A1
20100016804 Muskatello et al. Jan 2010 A1
20100036331 Sen Feb 2010 A1
20100094310 Warring et al. Apr 2010 A1
20100106135 Radmand Apr 2010 A1
20100114063 Recinella et al. May 2010 A1
20100137815 Kuracina et al. Jun 2010 A1
20100137833 Glynn Jun 2010 A1
20100168675 Cindrich et al. Jul 2010 A1
20100204648 Stout et al. Aug 2010 A1
20100210934 Belson Aug 2010 A1
20100222746 Burkholz Sep 2010 A1
20100234804 Hiejima et al. Sep 2010 A1
20100241088 Ranalletta et al. Sep 2010 A1
20100262038 Tan et al. Oct 2010 A1
20100262083 Grunhut et al. Oct 2010 A1
20100268156 Milacek et al. Oct 2010 A1
20100274199 Weston Oct 2010 A1
20100286615 Gyrn et al. Nov 2010 A1
20100286620 Edginton et al. Nov 2010 A1
20100286623 Liversidge Nov 2010 A1
20100292673 Korogi et al. Nov 2010 A1
20100305519 McKinnon et al. Dec 2010 A1
20100318063 Soll Dec 2010 A1
20110015573 Maan et al. Jan 2011 A1
20110021994 Anderson et al. Jan 2011 A1
20110040281 White et al. Feb 2011 A1
20110054404 Tanabe et al. Mar 2011 A1
20110060288 Carlyon et al. Mar 2011 A1
20110077592 Takemoto Mar 2011 A1
20110125096 Baid May 2011 A1
20110125097 Shaw et al. May 2011 A1
20110178427 Tan et al. Jul 2011 A1
20110178464 Rawls Jul 2011 A1
20110178478 Huet et al. Jul 2011 A1
20110196260 Melsheimer et al. Aug 2011 A1
20110208124 Rhad et al. Aug 2011 A1
20110213307 Kawai et al. Sep 2011 A1
20110224617 Miner Sep 2011 A1
20110306933 Djordjevic et al. Dec 2011 A1
20110319859 Zeytoonian et al. Dec 2011 A1
20120010577 Liska et al. Jan 2012 A1
20120016312 Brown et al. Jan 2012 A1
20120022464 Zivkovic et al. Jan 2012 A1
20120035552 Woehr Feb 2012 A1
20120041371 Tal et al. Feb 2012 A1
20120041377 Haak Feb 2012 A1
20120056746 Kaigler et al. Mar 2012 A1
20120065612 Stout et al. Mar 2012 A1
20120109077 Ryan May 2012 A1
20120123381 Kraus et al. May 2012 A1
20120143151 Low et al. Jun 2012 A1
20120150117 Andino Jun 2012 A1
20120150121 Silverman et al. Jun 2012 A1
20120153201 Larose et al. Jun 2012 A1
20120184910 Woehr Jul 2012 A1
20120191010 Cabot Jul 2012 A1
20120191071 Butts et al. Jul 2012 A1
20120197200 Belson Aug 2012 A1
20120197205 Peters Aug 2012 A1
20120220944 Charlez Aug 2012 A1
20120220955 Maseda et al. Aug 2012 A1
20120220956 Kuracina et al. Aug 2012 A1
20120220984 Christensen et al. Aug 2012 A1
20120226240 Bedford et al. Sep 2012 A1
20120259293 Bialecki et al. Oct 2012 A1
20120316536 Carrez et al. Dec 2012 A1
20120323181 Shaw et al. Dec 2012 A1
20120330248 Woehr Dec 2012 A1
20130030370 Walker et al. Jan 2013 A1
20130041313 Chung Feb 2013 A1
20130053781 Woehr et al. Feb 2013 A1
20130053815 Mucientes et al. Feb 2013 A1
20130060197 Woehr et al. Mar 2013 A1
20130060198 Woehr et al. Mar 2013 A1
20130060199 Baid Mar 2013 A1
20130060201 Popov Mar 2013 A1
20130060205 Mansour et al. Mar 2013 A1
20130066276 Ito et al. Mar 2013 A1
20130079730 Mosier et al. Mar 2013 A1
20130096504 Walker et al. Apr 2013 A1
20130110036 Fojtik May 2013 A1
20130116598 Howell et al. May 2013 A1
20130150784 Rodriguez Lelis et al. Jun 2013 A1
20130158506 White et al. Jun 2013 A1
20130178798 Pearson et al. Jul 2013 A1
20130178825 Helm, Jr. Jul 2013 A1
20130211325 Wang et al. Aug 2013 A1
20130226144 Milligan Aug 2013 A1
20130231630 Kraus et al. Sep 2013 A1
20130261554 Baid Oct 2013 A1
20130296808 Triplett et al. Nov 2013 A1
20140012196 Zivkovic et al. Jan 2014 A1
20140012206 Shaw et al. Jan 2014 A1
20140025036 Bierman et al. Jan 2014 A1
20140039399 Burkholz Feb 2014 A1
20140052065 Woehr et al. Feb 2014 A1
20140058329 Walker et al. Feb 2014 A1
20140058357 Keyser et al. Feb 2014 A1
20140074032 Bornhoft Mar 2014 A1
20140081210 Bierman et al. Mar 2014 A1
20140100528 Finnestad et al. Apr 2014 A1
20140107619 Butts et al. Apr 2014 A1
20140135702 Woehr et al. May 2014 A1
20140135703 Yeh et al. May 2014 A1
20140163470 Baid Jun 2014 A1
20140163523 Constantineau et al. Jun 2014 A1
20140171876 Shaw et al. Jun 2014 A1
20140174578 Bonnal et al. Jun 2014 A1
20140180212 Baid Jun 2014 A1
20140180219 Ho et al. Jun 2014 A1
20140180250 Belson Jun 2014 A1
20140180258 Ho et al. Jun 2014 A1
20140188003 Belson Jul 2014 A1
20140209197 Carrez et al. Jul 2014 A1
20140221931 Kuracina et al. Aug 2014 A1
20140257202 Woehr Sep 2014 A1
20140261860 Heath et al. Sep 2014 A1
20140276453 Woehr Sep 2014 A1
20140276455 Yeh et al. Sep 2014 A1
20140276458 Mansour et al. Sep 2014 A1
20140276459 Yeh et al. Sep 2014 A1
20140276462 Vincent et al. Sep 2014 A1
20140276463 Mansour et al. Sep 2014 A1
20140276466 Yeh et al. Sep 2014 A1
20140296794 Li Oct 2014 A1
20140296829 White et al. Oct 2014 A1
20140303561 Li Oct 2014 A1
20140316350 Yamaguchi et al. Oct 2014 A1
20140323980 Cronenberg et al. Oct 2014 A1
20140336582 Tisci et al. Nov 2014 A1
20140336583 Morrissey et al. Nov 2014 A1
20140358033 Lynn Dec 2014 A1
20140364809 Isaacson et al. Dec 2014 A1
20140371686 Sano et al. Dec 2014 A1
20150005718 Walker et al. Jan 2015 A1
20150038943 Warring et al. Feb 2015 A1
20150045746 Macy, Jr. et al. Feb 2015 A1
20150073304 Miller Mar 2015 A1
20150080801 Tanabe et al. Mar 2015 A1
20150148748 Shluzas et al. May 2015 A1
20150148749 Cohn May 2015 A1
20150148756 Lynn May 2015 A1
20150151083 White et al. Jun 2015 A1
20150157799 Chen et al. Jun 2015 A1
20150157800 Chen et al. Jun 2015 A1
20150157848 Wu et al. Jun 2015 A1
20150165132 Perot et al. Jun 2015 A1
20150174339 Bokelman et al. Jun 2015 A1
20150174374 Woehr Jun 2015 A1
20150190168 Bierman et al. Jul 2015 A1
20150190627 Ueda et al. Jul 2015 A1
20150196737 Baid Jul 2015 A1
20150196749 Ziv et al. Jul 2015 A1
20150196750 Ueda et al. Jul 2015 A1
20150202424 Harton Jul 2015 A1
20150209508 Constantineu et al. Jul 2015 A1
20150224267 Farrell et al. Aug 2015 A1
20150258325 Panian et al. Sep 2015 A1
20150265829 Truitt et al. Sep 2015 A1
20150290431 Hall et al. Oct 2015 A1
20150297817 Guala Oct 2015 A1
20150297880 Ogawa et al. Oct 2015 A1
20150313523 Chelak et al. Nov 2015 A1
20150328438 Baid Nov 2015 A1
20150352331 Helm, Jr. Dec 2015 A1
20150352333 Arellano Cabrera et al. Dec 2015 A1
20160000364 Mendels et al. Jan 2016 A1
20160001057 Lopez et al. Jan 2016 A1
20160015943 Belson et al. Jan 2016 A1
20160015945 Warring et al. Jan 2016 A1
20160015958 Ueda et al. Jan 2016 A1
20160015961 Mansour et al. Jan 2016 A1
20160022963 Belson Jan 2016 A1
20160022977 Ueda et al. Jan 2016 A1
20160022978 Ueda Jan 2016 A1
20160030730 Mosler et al. Feb 2016 A1
20160038730 Zollinger Feb 2016 A1
20160088995 Ueda et al. Mar 2016 A1
20160114136 Woeher Apr 2016 A1
20160114137 Woehr et al. Apr 2016 A1
20160114147 Siopes et al. Apr 2016 A1
20160121082 Emmert et al. May 2016 A1
20160129180 Roman et al. May 2016 A1
20160135841 Albert et al. May 2016 A1
20160136051 Lavi May 2016 A1
20160158498 White et al. Jun 2016 A1
20160158499 Helm Jun 2016 A1
20160158524 Quach et al. Jun 2016 A1
20160183976 Bertoli et al. Jun 2016 A1
20160199575 Belley et al. Jul 2016 A1
20160206813 Abe et al. Jul 2016 A1
20160206858 Ishida Jul 2016 A1
20160220270 Tamura et al. Aug 2016 A1
20160235944 Ma Aug 2016 A1
20160235949 Baid Aug 2016 A1
20160235961 Maffei Aug 2016 A1
20160256667 Ribelin et al. Sep 2016 A1
20160263353 Kuracina et al. Sep 2016 A1
20160271370 Keyser et al. Sep 2016 A1
20160296724 Goral et al. Oct 2016 A1
20160325078 Burkholz Nov 2016 A1
20170000983 Woehr Jan 2017 A1
20170182293 Chhikara Jun 2017 A1
20170239443 Abitabilo et al. Aug 2017 A1
20190091448 Chhikara Mar 2019 A1
20190282784 Farrell Sep 2019 A1
20210093834 Chhikara Apr 2021 A1
Foreign Referenced Citations (25)
Number Date Country
101466431 Jun 2009 CN
0 576 302 Dec 1993 EP
0 821 980 Apr 2003 EP
1 323 442 Jul 2003 EP
56-130161 Oct 1981 JP
03-501818 Apr 1991 JP
H06-78999 Mar 1994 JP
10-015075 Jan 1998 JP
2901915 Jun 1999 JP
2005-261931 Sep 2005 JP
2008-528225 Jul 2008 JP
4211858 Jan 2009 JP
WO 199001351 Feb 1990 WO
WO 1997015342 May 1997 WO
WO 2006082350 Aug 2006 WO
WO 2006090148 Aug 2006 WO
WO 2007052656 May 2007 WO
WO 2007143555 Dec 2007 WO
WO 2008042285 Apr 2008 WO
WO 2009032008 Mar 2009 WO
WO 2009092076 Jul 2009 WO
WO 2011146764 Nov 2011 WO
WO 2011146769 Nov 2011 WO
WO 2015119940 Aug 2015 WO
WO 2018009653 Jan 2018 WO
Non-Patent Literature Citations (5)
Entry
U.S. Appl. No. 15/427,714, filed Feb. 8, 2017, White et al.
U.S. Appl. No. 15/951,509, filed Apr. 12, 2018, White et al.
BD Nexiva Closed IV Catheter System, http://www.bd.com/infusion/products/ivcatheters/nexiva/index.asp, downloaded Sep. 6, 2013 in 19 pages.
International Preliminary Reporton Patentability, re PCT Application No. PCT/US2011/037239, dated Nov. 20, 2012.
International Search Report and Written Opinion, re PCT Application No. PCT/US2011/037239, dated Oct. 26, 2011.
Related Publications (1)
Number Date Country
20200289791 A1 Sep 2020 US
Provisional Applications (8)
Number Date Country
61448318 Mar 2011 US
61438774 Feb 2011 US
61438782 Feb 2011 US
61418358 Nov 2010 US
61418349 Nov 2010 US
61407797 Oct 2010 US
61356776 Jun 2010 US
61346292 May 2010 US
Continuations (3)
Number Date Country
Parent 15821680 Nov 2017 US
Child 16794535 US
Parent 14267811 May 2014 US
Child 15821680 US
Parent 13111693 May 2011 US
Child 14267811 US